Literature DB >> 23229232

High mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cells.

Yang Xi1, Yu-Sang Li, He-Bin Tang.   

Abstract

Active mutations of Notch1 play pivotal roles during leukemogenesis, but the downstream targets and molecular mechanisms of activated Notch1 signaling have not yet been fully clarified. In this study, we detected the overexpression of the high mobility group A1 (HMGA1) and activation of Notch1 signaling in mouse thymic lymphomas. A direct regulation of Notch1 on HMGA1 transcription was demonstrated and two Notch1/RBPJ cobinding sites of T/CTCCCACA were found in HMGA1 promoter regions. It was the first time demonstrated that HMGA1 was the downstream target of Notch1 signaling. Moreover, knockdown of HMGA1 resulted in significantly impaired cell growth and decreased expressions of cyclin D and cyclin E in human T leukemia cells. The formation of complexes was also observed between HMGA1 and retinoblastoma (RB) protein indicating a mechanism of cell cycle regulation. These findings suggest that activated HMGA1 regulates cell proliferation through the Notch1 signaling pathway, which represents an important molecular pathway leading to leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229232     DOI: 10.1007/s11010-012-1517-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

Review 2.  Notch signalling during peripheral T-cell activation and differentiation.

Authors:  Barbara A Osborne; Lisa M Minter
Journal:  Nat Rev Immunol       Date:  2006-12-15       Impact factor: 53.106

Review 3.  RB and cell cycle progression.

Authors:  C Giacinti; A Giordano
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

4.  HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.

Authors:  Monica Fedele; Rosa Visone; Ivana De Martino; Giancarlo Troncone; Dario Palmieri; Sabrina Battista; Andrea Ciarmiello; Pierlorenzo Pallante; Claudio Arra; Rosa Marina Melillo; Kristian Helin; Carlo Maria Croce; Alfredo Fusco
Journal:  Cancer Cell       Date:  2006-06       Impact factor: 31.743

Review 5.  Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.

Authors:  Clemens Grabher; Harald von Boehmer; A Thomas Look
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

6.  High mobility group protein HMGA1 inhibits retinoblastoma protein-mediated cellular G0 arrest.

Authors:  Yasuaki Ueda; Sugiko Watanabe; Shuchin Tei; Noriko Saitoh; Jun-Ichi Kuratsu; Mitsuyoshi Nakao
Journal:  Cancer Sci       Date:  2007-09-17       Impact factor: 6.716

7.  Interaction between HMGA1 and retinoblastoma protein is required for adipocyte differentiation.

Authors:  Francesco Esposito; Giovanna Maria Pierantoni; Sabrina Battista; Rosa Marina Melillo; Stefania Scala; Paolo Chieffi; Monica Fedele; Alfredo Fusco
Journal:  J Biol Chem       Date:  2009-07-26       Impact factor: 5.157

8.  Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome.

Authors:  D Thanos; T Maniatis
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

Review 9.  Notch signaling in embryonic and adult myelopoiesis.

Authors:  Ralf Schwanbeck; Timm Schroeder; Konstanze Henning; Hella Kohlhof; Nikolaus Rieber; Maria-Luise Erfurth; Ursula Just
Journal:  Cells Tissues Organs       Date:  2008-01-16       Impact factor: 2.481

10.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.

Authors:  W S Pear; J C Aster; M L Scott; R P Hasserjian; B Soffer; J Sklar; D Baltimore
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  5 in total

1.  Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.

Authors:  Ze Zhang; Quan Wang; Feng Chen; Jun Liu
Journal:  Tumour Biol       Date:  2014-10-25

Review 2.  High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.

Authors:  Lu Wang; Ji Zhang; Min Xia; Chang Liu; Xuyu Zu; Jing Zhong
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

3.  MicroRNA-296-5p inhibits cell proliferation by targeting HMGA1 in colorectal cancer.

Authors:  Guohui Yan; Shuidi Yan; Jiajia Wang; Shen Lei; Weimin Tian; Xin Yue; Yang Zhang
Journal:  Exp Ther Med       Date:  2021-05-24       Impact factor: 2.447

Review 4.  Interplay between HMGA and TP53 in cell cycle control along tumor progression.

Authors:  Nathalia Meireles Da Costa; Antonio Palumbo; Marco De Martino; Alfredo Fusco; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti
Journal:  Cell Mol Life Sci       Date:  2020-09-12       Impact factor: 9.261

5.  The proliferation of cervical cancer is promoted by miRNA-125b through the regulation of the HMGA1.

Authors:  Bingmei Sun; Ying Zhang; Lianxiang Zhou; Linin Yin; Fei Li; Chao Li; Jiayu Xia
Journal:  Onco Targets Ther       Date:  2019-04-11       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.